Two-Year Data from INNOVATION Trial Continues to Demonstrate Safety and Performance in Treatment of AAAs

Published date : 01 June 2014
Article date : 28 January 2014

Cordis Corporation announced the presentation of two-year data from its INNOVATION Trial at the 2014 Leipzig Interventional Course (LINC) in Germany. Data from the study continues to demonstrate that the INCRAFT® System performs well in patients suffering from abdominal aortic aneurysms (AAA) two years after treatment.

Read the manufacturer's press release here

Back to Listings

WhichMedicalDevice is a FREE resource created by clinicians for clinicians.

Registration is free and gives you unlimited access to all of the content and features of this website.

Find out more...

Please sign in to view this content...

I have forgotten my password
Not a Member?

Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...

Why Register

Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.

We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.

Selecting this option will remember your log in details whenever you return to this website. DO NOT use this option if you share this computer with others.

Stay up to date with the latest news and reviews from Which Medical Device

Tell a colleague about Which Medical Device and boost your Impact Factor

Selecting this option will remember your log in details whenever you return to this website. DO NOT use this option if you share this computer with others.